Cyclooxygenase-2 inhibition partially protects against 60% o2-mediated lung injury in neonatal rats

Pediatric Pulmonology

Volumn 49, Issue 10, 2014, Pages 991-1002

  Masood, Azhar ^a,b   Yi, Man ^c   Lau, Mandy ^a,b   Belcastro, Rosetta ^a   Li, Jun ^a   Kantores, Crystal ^a   Pace Asciak, Cecil R ^a,b   Jankov, Robert P ^a,b,d   Tanswell, A Keith ^a,b,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alveolar formation; Bronchopulmonary dysplasia; Chronic neonatal lung injury; PGE2

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; CYCLOOXYGENASE 2; OXYGEN; PROSTAGLANDIN E2; 5,5-DIMETHYL-3-(3-FLUOROPHENYL)-4-(4-METHYLSULFONYL)PHENYL-2(5H)-FURANONE; CYCLOOXYGENASE 2 INHIBITOR; FURAN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BODY WEIGHT; CELL POPULATION; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DOSIMETRY; FIBROBLAST; INFLAMMATORY CELL; LUNG ALVEOLUS MACROPHAGE; LUNG DYSPLASIA; LUNG FIBROBLAST; LUNG HOMOGENATE; LUNG INJURY; LUNG VOLUME; MESENCHYME CELL; NEUTROPHIL; NEWBORN; NONHUMAN; RAT; ANIMAL; BRONCHOPULMONARY DYSPLASIA; LUNG; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; BRONCHOPULMONARY DYSPLASIA; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; FURANS; LUNG; OXYGEN; RATS, SPRAGUE-DAWLEY;

EID: 84908164846     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22921     Document Type: Article

References (44)

1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-1729.
2. Coalson JJ. Pathology of chronic lung disease of early infancy. In: Bland RD, Coalson JJ, editors. Chronic lung disease in early infancy. New York: Dekker; 1999. pp 85-124.
3. Burri PH. Structural aspects of prenatal and postnatal development and growth of the lung. In: McDonald JA, editor. Lung growth and development. New York: Dekker; 1997; pp 1-35.
4. Han RNN, Buch S, Tseu I, Young J, Christie NA, Frndova H, Lye SJ, Post M, Tanswell AK. Changes in structure, mechanics, and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% oxygen. Pediatr Res 1966;39:921-929.
5. Cutz E, Chaisson D. Chronic lung disease after premature birth. N Eng J Med 2008;358:743-746.
6. Wong PM, Lees AN, Louw J, Lee FY, French N, Gain K, Murray CP, Wilson A, Chambers DC. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J 2008;32:321-328.
7. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, Yurman S, Dolfin T, Kogan A, Dollberg S, Arbel E, Goldberg M, Gur I, Naor N, Sirota L, Mogilner S, Zaritsky A, Barak M, Gottfreid E. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child 2000;88: F177-F181.
8. Blanco FJ, Guitian R, Moreno J, de Toro FJ, Galdo F. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J Rheumatol 1999;26:1366-1373.
9. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, Solimano A, Vincer M, Wright LL. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001;344:1966-1972.
10. Jankov RP, Belcastro R, Ovcina E, Lee J, Massaeli H, Lye SJ, Tanswell AK. Thromboxane A2 receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism. Am J Respir Crit Care Med 2002;166:208-214.
11. Lama V, Moore BB, Christensen P, Toews GB, Peters-Golden M. Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. Am J Respir Cell Mol Biol 2002;27:752-758.
12. Maniscalco WM, Watkins RH, O'Reilly MA, Shea CP. Increased epithelial cell proliferation in very premature baboons with chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2002;283:L991-L1001.
13. Padela S, Cabacungan J, Shek S, Belcastro R, Yi M, Jankov RP, Tanswell AK. Hepatocyte growth factor is required for alveologenesis in the neonatal rat. Am J Respir Crit Care Med 2005;172:907-914.
14. Turner CR, Quinlan MF, Schwartz LW, Wheeldon EB. Therapeutic intervention in a rat model of ARDS: I. Dual inhibition of arachidonic acid metabolism. Circ Shock 1990;32:231-242.
15. Turner CR, Lackey MN, Quinlan MF, Schwartz LW, Wheeldon EB. Therapeutic intervention in a rat model of adult respiratory distress syndrome: III. Cyclooxygenase pathway inhibition. Circ Shock 1991;34:270-277.
16. Jin LD,Wang LR,Wang LQ, Shan YL, Zhao XY, Xiong XQ, Zhou JH, Lin LN, Jin LL. Effects of COX-2 inhibitor on ventilationinduced lung injury in rats. Int Immunopharmacol 2013;16:288-295.
17. Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol 2005;174:5033-5039.
18. Kuniyoshi KM, Brock RS, Gebrekristos Abad-Santos M, Hoang D, Modanlou HD, Willis BC, Beharry K. Effects of combined hyperoxia and cyclooxygenase inhibition in neonatal rat lungs. Am J Transl Res 2010;2:332-344.
19. Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret J-P, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Leger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Therien M, Wang Z,Webb JK,Wong E, Xu L, Young RN, Zamboni R, Prasit P, Chan C-C. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 1997;121:105-117.
20. Jankov RP, Luo X, Belcastro R, Copland I, Frndova H, Lye SJ, Hoidal JR, Post M, Tanswell AK. Gadolinium chloride inhibits pulmonary macrophage influx and prevents O2-induced pulmonary hypertension in the neonatal rat. Pediatr Res 2001;50:172-183.
21. Yi M, Jankov RP, Belcastro R, Humes D, Copland I, Shek S, Sweezey NB, Post M, Albertine KH, Auten RL, Tanswell AK. Opposing effects of 60% oxygen and neutrophil influx on alveologenesis in the neonatal rat. Am J Respir Crit Care Med 2004;170:1188-1196.
22. Masood A, Yi M, Lau M, Belcastro R, Shek S, Pan J, Kantores C, McNamara PJ, Kavanagh BP, Belik J, Jankov RP, Tanswell AK. Therapeutic effects of hypercapnia on chronic lung injury and vascular remodeling in neonatal rats. Am J Physiol Lung Cell Mol Physiol 2009;297:L920-L930.
23. Masood A, Belcastro R, Li J, Kantores C, Jankov RP, Tanswell AK. A peroxynitrite decomposition catalyst prevents 60% O2-mediated rat chronic neonatal lung injury. Free Rad Biol Med 2010;49:1182-1191.
24. Yi M, Masood A, Ziino A, Johnson B-H, Belcastro R, Li J, Shek S, Kantores C, Jankov RP, Tanswell AK. Inhibition of apoptosis by 60% oxygen: a novel pathway contributing to lung injury in neonatal rats. Am J Physiol 2011;300:L319-L329.
25. Santangelo S, Shoup M, Gamelli RL, Shankar R. Prostaglandin E2 receptor antagonist (SC-19220) treatment restores the balance to bone marrow myelopoiesis after burn sepsis. J Trauma Inj Infect Crit Care 2000;48:826-830.
26. Yi M, Belcastro R, Shek S, Luo D, Post M, Tanswell AK. Fibroblast growth factor-2 and receptor-1alpha(IIIc) regulate postnatal rat lung cell apoptosis. Am J Respir Crit Care Med 2006;174:581-589.
27. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
28. Frid MG, Brunetti JA, Burke DL, Carpenter TC, Davie NJ, Reeves JT, Roedersheimer MT, van Rooijen N, Stenmark KR. Hypoxiainduced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 2006;168:659-669.
29. Brumley GW, Chernick V, Hodson WA, Normand C, Fenner A, Avery ME. Correlations of mechanical stability, morphology, pulmonary surfactant, and phospholipid content in the developing lamb lung. J Clin Invest 1967;46:863-873.
30. Padela S, Yi M, Cabacungan J, Shek S, Belcastro R, Masood A, Jankov RP, Tanswell AK. A critical role for fibroblast growth factor-7 during early alveolar formation in the neonatal rat. Pediatr Res 2008;63:232-238.
31. Dunnill M. Quantitative methods in the study of pulmonary pathology. Thorax 1962;17:320-328.
32. Weibel ER, Gomez DM. A principle for counting tissue structures on random sections. J Appl Physiol 1962;17:343-348.
33. Schittny JC, Mund SI, Stampanoni M. Evidence and structural mechanism for late lung alveolarization. Am J Physiol Lung Cell Mol Physiol 2008;294:L246-L254.
34. Sheehan D, Hrapchak B, editors. Theory and practice of histotechnology. Ohio. Battelle Press; 1980; 194-195 pp.
35. Jamal M, Masood A, Belcastro R, Lopez L, Li J, Belik J, Jankov RP, Tanswell AK. Lipid hydroperoxide formation regulates postnatal rat lung cell apoptosis and alveologenesis. Free Rad Biol Med 2013;55:83-92.
36. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976;72:248-254.
37. Duggan M, McNamara P, Engelberts D, Pace-Asciak C, Babyn P, Post M, Kavanagh B. Oxygen attenuates atelectasis-induced injury in the in vivo rat lung. Anesthesiology 2005;103:522-531.
38. Tanswell AK, Olson DA, Freeman BA. Response of fetal rat lung fibroblasts to elevated oxygen concentrations after liposomemediated augmentation of antioxidant enzymes. Biochim Biophys Acta 1990;1044:269-274.
39. Luo X, Christie NA, McLaughlin MA, Belcastro R, Sedlackova L, Cabacungan J, Freeman BA, Tanswell AK. H2O2 mediates O2 toxicity in cultured fetal rat distal lung epithelial cells. Free Rad Biol Med 1999;26:1357-1368.
40. Thurlbeck WM. Postnatal growth and development of the lung. Am Rev Respir Dis 1975;111:803-844.
41. Johnson B-H, Yi M, Masood A, Belcastro R, Shek S, Kantores C, Jankov RP, Tanswell AK. A critical role for interleukin-1 receptor in the lung injury induced in neonatal rats by 60% oxygen. Pediatr Res 2009;66:260-265.
42. Schmidt B, Roberts RS, Fanaroff A, Davis P, Kirpalani HM, Nwaesei C, Vincer M. TIPP Investigators. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr 2006; 148:730-734.
43. Nagai A, Katayama M, Thurlbeck WM, Matsui R, Yasui S, Konno K. Effect of indomethacin on lung development in postnatal rats: possible role of prostaglandin in alveolar formation. Am J Physiol Lung Cell Mol Physiol 1995;268: L56-L62.
44. McCurnin D, Seidner S, Chang LY, Waleh N, Ikegami M, Petershack J, Yoder B, Giavedoni L, Albertine KH, Dahl MJ, Wang ZM, Clyman RI. Ibuprofen-induced patent ductus arteriosus closure: physiologic, histologic and biochemical effects on the premature lung. Pediatrics 2008 121:945-956.